Advancing Gene and Cell Product Development Through iPSC and Genome Editing Technologies Applied StemCell strives to advance gene-editing and stem cell innovation for biomedical research and the biotechnology industry to assist in the development of breakthrough therapeutic approaches to cure intractable diseases. ASC is a trailblazing CRO/CDMO committed to building a complete iPSC-Gene Editing platform for the production of iPSC-derived products for gene and cell therapy research and development. With the integration of our unique iPSC approach and IP-based site-specific large cargo insertion technology, TARGATT™, we (1) develop immune-compatible master iPS cell lines and (2) deliver large DNA fragments to pluripotent cells that have proven differentiation capabilities. We stand at the forefront of the iPSC-based therapy revolution delivering research- and GMP-grade iPSC solutions along with various downstream assay services. Current Offerings: • iPSC Cell Line Models: iPSC generation, CRISPR & TARGATT™ genome editing, differentiation • Cell Gene Product CDMO: TARGATT™ iPSC Platform for allogeneic cell therapy products/GMP iPSC reprogramming, cell banking, gene editing, and differentiation • Bioproduction: TARGATT™ CHO cell system for antibody screening and bioproduction/TARGATT™ HEK293 cell system for library/antibody screening • Animal Models: Custom and off-the-shelf CRISPR & TARGATT™ mouse models For patent licensing, business development, and investment inquiries, please contact us at info@appliedstemcell.com.
View Top Employees from Applied StemCell| Website | https://www.appliedstemcell.com/ |
| Revenue | $66 million |
| Funding | $23.1 million |
| Employees | 46 (35 on RocketReach) |
| Founded | 2008 |
| Address | 521 Cottonwood Drive Suite 111, Milpitas, California 95035, US |
| Phone | (408) 773-8007 |
| Fax | (650) 800-7179 |
| Technologies |
JavaScript,
HTML,
Font Awesome
+24 more
(view full list)
|
| Industry | Biotechnology Research, Business Services General, Biotechnology, Genome Editing, Business Services, Science and Engineering, Mouse Rat Model Generation, Genetics, Cell Line Models, Health Care, Ipsc Disease Modeling, Health Diagnostics, Ipsc Differentiation, Medical |
| Web Rank | 973839 |
| Keywords | Hipsc Derived Neurons Neun Staining, Applied Stem Cell Inc, Applied Stemcell , Inc . , Milpitas , Ca, Crispr/Cas9 Point Mutation Heterozygous Clone, Apoe4 Neural Progenitor Cells, Applied Stemcell Fosun, Crispr Cas9, Biolegend Antibody Validation, E.Coli Gmp Protein Production |
| Competitors | CRISPR Therapeutics, EdiGene Inc., Editas Medicine, Precision BioSciences, Inc., 赛业(广州)生物科技有限公司 |
| SIC | SIC Code 873 Companies, SIC Code 8734 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 541 Companies, NAICS Code 54138 Companies, NAICS Code 54 Companies, NAICS Code 5413 Companies |
Looking for a particular Applied StemCell employee's phone or email?
Applied StemCell Questions
The Applied StemCell annual revenue was $66 million in 2024.
35 people are employed at Applied StemCell.
Applied StemCell is based in Milpitas, California.
The NAICS codes for Applied StemCell are [541, 54138, 54, 5413].
The SIC codes for Applied StemCell are [873, 8734, 87].
Top Applied StemCell Employees
-
32
-
ViewIris Lin
Senior FACS Manager and Associate Scientist, Operation and GMP production at Applied StemCell
California, United States22 -
11
-
11
-
ViewSimon Wu
Associate Director of Technical Operations and Project Management at Applied StemCell
California, United States22 -
11
-
22
-
1
-
ViewJinling Li
Senior Vice President, Scientific Alliances at Applied StemCell
Milpitas, California, United States23
Related Companies
